4/25
09:19 am
bcda
BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort [Yahoo! Finance]
Low
Report
BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort [Yahoo! Finance]
4/25
09:00 am
bcda
BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
Low
Report
BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
4/1
02:42 pm
bcda
BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/27
04:09 pm
bcda
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results [Yahoo! Finance]
Low
Report
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results [Yahoo! Finance]
3/27
04:00 pm
bcda
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
Low
Report
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
3/20
07:12 am
bcda
BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024 [Yahoo! Finance]
Medium
Report
BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024 [Yahoo! Finance]
3/20
07:00 am
bcda
BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024
Medium
Report
BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024
3/13
08:39 am
bcda
BioCardia and StemCardia partners for heart failure treatment candidate [Seeking Alpha]
Low
Report
BioCardia and StemCardia partners for heart failure treatment candidate [Seeking Alpha]
3/13
07:00 am
bcda
BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership
Low
Report
BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership
3/12
09:02 am
bcda
BioCardia spikes after Medicare coverage for cell therapy trial [Seeking Alpha]
High
Report
BioCardia spikes after Medicare coverage for cell therapy trial [Seeking Alpha]
3/12
07:17 am
bcda
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study [Yahoo! Finance]
High
Report
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study [Yahoo! Finance]
3/12
07:00 am
bcda
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
High
Report
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
3/4
08:09 am
bcda
BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure [Yahoo! Finance]
High
Report
BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure [Yahoo! Finance]
3/4
08:00 am
bcda
BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure
High
Report
BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure
2/8
07:19 am
bcda
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA [Yahoo! Finance]
High
Report
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA [Yahoo! Finance]
2/8
07:00 am
bcda
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA
High
Report
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA
1/31
07:12 am
bcda
BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference [Yahoo! Finance]
Medium
Report
BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference [Yahoo! Finance]
1/31
07:00 am
bcda
BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference
Medium
Report
BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference